Hans C Ebbers

6PUBLICATIONS
11CO-AUTHORS
Epidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomechanical engineeringMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2025
Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study.

Jerome Sepin, Thomas P A Debray, Wei Wei

|Apr 08, 2025
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product.

Hans C Ebbers, Peter C Taylor, Xiaomei Leng

|Mar 06, 2025
Comparative Structure Activity Relationship Characterization of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab.

Yujie Liu, Jianhua Xie, Zhuxiang Li

|Aug 21, 2024
Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab.

Yujie Liu, Jianhua Xie, Zhuxiang Li

|Jun 18, 2024
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab.

Yujie Liu, Jianhua Xie, Zhuxiang Li

|Jan 29, 2024
A Retrospective Analysis of the Potential Impact of Differences in Aggregates on Clinical Immunogenicity of Biosimilars and their Reference Products.

Cristina Fernandez-Mendivil, Niamh M Kinsella, Hans C Ebbers

Pageof 1